[go: up one dir, main page]

MX9702666A - Nuevos peptidos con efectos inmunoreguladores. - Google Patents

Nuevos peptidos con efectos inmunoreguladores.

Info

Publication number
MX9702666A
MX9702666A MX9702666A MX9702666A MX9702666A MX 9702666 A MX9702666 A MX 9702666A MX 9702666 A MX9702666 A MX 9702666A MX 9702666 A MX9702666 A MX 9702666A MX 9702666 A MX9702666 A MX 9702666A
Authority
MX
Mexico
Prior art keywords
new peptides
immunomodulatory effects
new
peptides
immunomodulatory
Prior art date
Application number
MX9702666A
Other languages
English (en)
Other versions
MXPA97002666A (es
Inventor
Hakan Bergstrand
Tomas Eriksson
Kostas Karabelas
Magnus Lindvall
Bengt Sarnstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MXPA97002666A publication Critical patent/MXPA97002666A/es
Publication of MX9702666A publication Critical patent/MX9702666A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Nuevos péptidos de acuerdo con la formula (I), A-X-Y-Cys-Z-B, un proceso para la preparacion y su uso en la fabricacion de preparaciones farmacéuticas. Los péptidos nuevos son excelentes como inmunoregulares.
MX9702666A 1994-10-14 1995-10-06 Nuevos peptidos con efectos inmunoreguladores. MX9702666A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9403526.8 1994-10-14
SE9403526A SE9403526D0 (sv) 1994-10-14 1994-10-14 New Peptides
PCT/SE1995/001151 WO1996011943A1 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects

Publications (2)

Publication Number Publication Date
MXPA97002666A MXPA97002666A (es) 1997-06-01
MX9702666A true MX9702666A (es) 1997-06-28

Family

ID=20395628

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9702666A MX9702666A (es) 1994-10-14 1995-10-06 Nuevos peptidos con efectos inmunoreguladores.

Country Status (20)

Country Link
US (2) US6103697A (es)
EP (1) EP0783519A1 (es)
JP (1) JPH10507448A (es)
AU (1) AU705364B2 (es)
BR (1) BR9509345A (es)
CA (1) CA2201479A1 (es)
CZ (1) CZ111997A3 (es)
EE (1) EE9700087A (es)
FI (1) FI971499A (es)
HU (1) HUT77118A (es)
IL (1) IL115509A0 (es)
IS (1) IS4459A (es)
MX (1) MX9702666A (es)
NO (1) NO971625L (es)
PL (1) PL319631A1 (es)
SE (1) SE9403526D0 (es)
SK (1) SK46797A3 (es)
TR (1) TR199501255A2 (es)
WO (1) WO1996011943A1 (es)
ZA (1) ZA958140B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
AU2417597A (en) * 1996-04-12 1997-11-07 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory ef fects
AU3453897A (en) * 1996-07-08 1998-02-02 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
SE9603465D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603467D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603462D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603466D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603461D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
WO1999019347A1 (en) * 1997-10-10 1999-04-22 Astrazeneca Ab Synthetic genes with immunomodulatory effects
WO1999062483A1 (en) * 1998-06-03 1999-12-09 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US8080560B2 (en) 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
PL1948782T3 (pl) 2005-04-25 2013-01-31 Cadila Pharmaceuticals Ltd Adiuwanty szczepionki
KR101363455B1 (ko) * 2011-09-09 2014-02-21 (주)케어젠 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
EP0300031A4 (en) 1987-01-28 1990-05-14 Ortho Pharma Corp IMMUNE SUPPRESSIVE PEPTIDES AND METHOD FOR THEIR USE.
FR2622700B1 (fr) 1987-10-30 1993-08-13 Aderegem Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein
WO1989010935A1 (en) * 1988-05-09 1989-11-16 Abbott Laboratories Atrial peptide derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
JP2596466B2 (ja) 1990-03-03 1997-04-02 アサヒビール株式会社 ダニの主要アレルゲンの還伝情報を有するｄｎａおよび該アレルゲンの製造方法
AU655599B2 (en) 1990-09-11 1995-01-05 Institute For Child Health Research Cloning and sequencing of allergens of dermatophagoides (house dust mite)
AU2296792A (en) * 1991-06-28 1993-01-25 Corvas International, Inc. Novel inhibitors of platelet aggregation
JP2657861B2 (ja) 1991-09-17 1997-09-30 アサヒビール株式会社 ダニ主要アレルゲンの製造方法
WO1993008279A1 (en) 1991-10-16 1993-04-29 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
JP3149033B2 (ja) 1991-10-30 2001-03-26 アサヒビール株式会社 ダニ主要アレルゲンＤｅｒ ｆ ＩＩ中のペプチド
CA2157510A1 (en) 1993-03-05 1994-09-15 Howard M. Grey Hla-a2.1 binding peptides and their uses
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
JPH07215996A (ja) 1994-01-31 1995-08-15 Torii Yakuhin Kk ダニアレルゲンのｂ細胞エピトープ
HU220344B (hu) 1994-07-05 2001-12-28 Steeno Research Group A/S Immunmodulátorok
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
EE9700087A (et) 1997-10-15
IS4459A (is) 1997-04-08
BR9509345A (pt) 1997-11-25
SK46797A3 (en) 1997-09-10
EP0783519A1 (en) 1997-07-16
WO1996011943A1 (en) 1996-04-25
FI971499A0 (fi) 1997-04-10
HUT77118A (hu) 1998-03-02
IL115509A0 (en) 1996-05-14
NO971625D0 (no) 1997-04-09
NO971625L (no) 1997-05-30
AU3713395A (en) 1996-05-06
AU705364B2 (en) 1999-05-20
FI971499A (fi) 1997-06-10
CA2201479A1 (en) 1996-04-25
CZ111997A3 (en) 1997-12-17
US6103697A (en) 2000-08-15
JPH10507448A (ja) 1998-07-21
US6228374B1 (en) 2001-05-08
TR199501255A2 (tr) 1996-06-21
PL319631A1 (en) 1997-08-18
SE9403526D0 (sv) 1994-10-14
ZA958140B (en) 1997-06-27

Similar Documents

Publication Publication Date Title
MX9702666A (es) Nuevos peptidos con efectos inmunoreguladores.
MX9700885A (es) Nuevas heteroariloxazolidinonas.
GR970100333A (el) Φαρμακευτικα παρασκευασματα για ενδορρινικη χορηγηση
ES8607732A1 (es) Procedimiento para producir un preparado implantable de un peptido regulador, uno de sus analogos o una de sus sales fisiologicamente compatibles.
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
DE69726714D1 (en) 9-oximsilyl erythromycin a derivate
CA2029678A1 (en) Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 14
ZA9710796B (en) Oxyiminopregnanecarbolactones.
DE69826520D1 (en) 6-o-alkylerythromycinoxim b
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
MY115211A (en) Novel amino acid derivatives, their preparation and use
EP1167354A3 (en) Racemic huperzine A
ES8801243A1 (es) Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
GEP20063972B (en) Streptogramin derivatives, preparation and compositions containing them
MX9704050A (es) P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n.
MX9803672A (es) Nuevos derivados de fenilamidina, procedimiento para su preparacion y su utilizacion como medicamentos.
CA2028629A1 (en) Antiandrogenically-effective pharmaceutical compositions
ATE272648T1 (de) Glycokonjugate von 20(s)-camptothecin
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
AU6697786A (en) New derivatives of 1-sulphonyl 2-oxo-5-alkoxy pyrrolidine, their preparation process, their use as medicaments and the compositions containing them
CA2111083A1 (en) Novel peptides, their preparation and use
MX9603092A (es) Nuevos compuestos con efecto analgesico y anestesico local.
IL74138A (en) 4,6,6a,7,8,12b-hexahydro-indolo(4,3-ab)phenanthridines,their production and pharmaceutical compositions containing them
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання